What’s new in cellular therapy? Drs. Maus and Locke highlight ongoing developments and look toward the future.
AML: Drs. Daver and Wang discuss emerging agents and combinations, including immunotherapy and targeted agents.
Hodgkin Lymphoma: Drs. Ansell and Moskowitz discuss evolving treatment approaches in HL.
Aggressive B-Cell Lymphoma: Drs. Sehn and Salles discuss emerging data and future directions in DLBCL.
Indolent B-cell Lymphoma: Drs. Nastoupil and Martin discuss recent advances and challenges in the treatment of patients with indolent B-cell lymphomas.